Toll Free: 1800 22 0369 / 1800 103 1369 Email Us: customercare@canmoney.in

Markets

Market

DIVI'S LABORATORIES LTD.

  • NSE CodeDIVISLABEQ
  • BSE Code532488
  • ISININE361B01024
  • IndustryPharmaceuticals

Company Information

Management

Mr. Y T S Prasad

General Manager

Mr. S Ramakrishna

General Manager

Mr. L Ramesh Babu

Vice President & CIO

Mr. L Kishore Babu

Chief Financial Officer

Incorporation Year

12/10/1990

Registered Address

Registered Office : Divi Towers, 1-72/23(P)/DIVIS/303, Cyber Hills, Gachibowli,
Hyderabad, Telangana - 500032
Tel: 040-23786300
Fax: 040-23786460

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

mail@divislabs.com

Website

http://www.divislabs.com

Listing

BSE, MCXSX, NSE

Corporate News

Divi's Lab - Schedule Of Earnings Conference Call Q2 ...

30-Oct-2020|11:05AM

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure R

Divi's Lab - Analysts/Institutional Investor Meet/Con...

30-Oct-2020|11:04AM

Divi's Laboratories Limited has informed the Exchange about Analysts/Instit

Divi's Lab - Board Meeting Intimation for Inter-Alia,...

27-Oct-2020|12:26PM

DIVI's LABORATORIES LTD.has informed BSE that the meeting of the Board of D

Divi's Lab - Intimation Under Regulation 30 Of The SE...

23-Oct-2020|2:07PM

We have earlier informed vide our letter dated 02 July, 2020 that SEBI has

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug25.0558.58
Aarti Drug680.956,346.45
Abbott India15,298.1532,507.50
ABL Bio-Tech0.810.66
Add LifePhrm0.466.89
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
SBI Equity Hy..1249.664.00
SBI Blue Chip..1075.414.88
Axis Long Ter..963.334.41
SBI ETF Nifty..599.380.80
Axis Focused ..547.214.78
More

Board Meetings

DatePurpose
07/11/2020Quarterly Results
08/08/2020Quarterly Results
06/06/2020Audited Results
12/02/2020Interim Dividend
05/02/2020Quarterly Results
More